Biotricity IncOTCQB:BTCY
- LAST PRICE0.2838
- TODAY'S CHANGE (%)-0.0062 (-2.1552%)
- Bid / Lots0.2710/ 55
- Ask / Lots0.2880/ 25
- Open / Previous Close0.2838 / 0.2900
- Day Range
- 52 Week Range
- Volume574
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BTCY |
|---|---|---|
| 10:13 ET | 500 | 0.28375 |
Nov 15, 2024
Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025, from 8:15AM ET on Friday Nov 15, 2024 by Dow Jones
8:15AM ET on Friday Nov 15, 2024 by Dow Jones*DJ Biotricity 2Q Rev $3.3M >BTCY, from 8:15AM ET on Friday Nov 15, 2024 by Dow Jones
8:15AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 13, 2024
Biotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15th, from 9:42AM ET on Wednesday Nov 13, 2024 by Dow Jones
9:42AM ET on Wednesday Nov 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biotricity Inc | 6.8M | -0.2x | --- |
Escalon Medical Corp | 1.2M | -6.3x | --- |
Lombard Medical Inc | 30.0 | 0.0x | --- |
LogicMark Inc | 3.2M | 0.0x | --- |
21st North Inc | 2.2K | 0.0x | --- |
Nuwellis Inc | 6.0M | 0.0x | --- |
Company Information
Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
Contact Information
- Headquarters
- 203 Redwood Parkway, Suite 600REDWOOD CITY, CA, United States 94065
- Phone
- 650-832-1626
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer
- Waqaas Al-Siddiq
- Chief Financial Officer
- John Ayanoglou
- Independent Director
- Ronald Mcclurg
- Independent Director
- David Rosa
- Independent Director
- Chester White
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.8M |
|---|---|
Revenue (TTM) | $12.6M |
Shares Outstanding | 24.4M |
Biotricity Inc does not pay a dividend. | |
Beta | 1.16 |
EPS | $-1.37 |
Book Value | $-3.15 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -46.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
